Zai Lab Limited ADR (NASDAQ: ZLAB) is 37.11% higher on its value in year-to-date trading and has touched a low of $13.48 and a high of $36.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ZLAB stock was last observed hovering at around $34.00 in the last trading session, with the day’s gains setting it 1.91%.
Currently trading at $35.91, the stock is 15.50% and 27.74% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.45 million and changing 5.62% at the moment leaves the stock 51.30% off its SMA200. ZLAB registered 70.19% gain for a year compared to 6-month gain of 80.09%.
The stock witnessed a 31.15% loss in the last 1 month and extending the period to 3 months gives it a 24.47%, and is 2.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.07% over the week and 5.32% over the month.
Zai Lab Limited ADR (ZLAB) has around 1869 employees, a market worth around $3.92B and $398.99M in sales. Fwd P/E is 92.30. Profit margin for the company is -64.44%. Distance from 52-week low is 166.39% and -1.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.08%).
The EPS is expected to grow by 40.51% this year
The shares outstanding are 109.14M, and float is at 108.11M with Short Float at 7.01%.
The top institutional shareholder in the company is WELLINGTON MANAGEMENT GROUP LLP with over 7.12 million shares valued at $123.47 million. The investor’s holdings represent 7.3211 of the ZLAB Shares outstanding. As of 2024-06-30, the second largest holder is JANUS HENDERSON GROUP PLC with 6.53 million shares valued at $113.13 million to account for 6.7077 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 1.66 million shares representing 1.7037 and valued at over $28.73 million, while FMR LLC holds 1.1633 of the shares totaling 1.13 million with a market value of $19.62 million.
Zai Lab Limited ADR (ZLAB) Insider Activity
Still, SEC filings show that on Feb 28 ’25, Edmondson Frazor Titus III (Chief Legal Officer) disposed off 14,544 shares at an average price of $32.98 for $0.48 million. The insider now directly holds 14,328 shares of Zai Lab Limited ADR (ZLAB).
Zai Lab Limited ADR (ZLAB): Who are the competitors?
One of the company’s main competitors (and peers) include Palvella Therapeutics Inc. (PVLA) that is trading 65.14% up over the past 12 months.Plandai Biotechnology Inc. (PLPL) lies in the list of competitors of the Zai Lab Limited ADR and is -99.38% lower over the same period from ZLAB
